Applications of Ubiquitination Proteomics in Biology and Medicine

Ubiquitination is a highly conserved and dynamically reversible post-translational modification (PTM) that involves the covalent attachment of ubiquitin molecules to substrate proteins, regulating their degradation, localization, activity, and protein-protein interaction networks.Ubiquitin modification not only maintains cellular homeostasis but also extensively participates in processes such as cell cycle regulation, DNA damage repair, signal transduction, metabolic regulation, and immune response. With the rapid development of mass spectrometry technology and specific enrichment strategies, ubiquitinomics has enabled the systematic and comprehensive depiction of the panorama of ubiquitin-modified proteins in cells or tissues, becoming a key technical path for understanding cell fate determination and disease mechanisms. Particularly in biological and medical research, ubiquitinomics has been widely applied to various hot directions including tumor early screening biomarker discovery, exploration of neurodegenerative disease mechanisms, and mining of immunotherapy targets, providing deep information support for precision medicine and new drug development.

 

I. Definitions Related to Ubiquitinomics

1. What is Ubiquitination?

Ubiquitin is a highly conserved small protein that connects to target proteins' lysine (K) or N-terminal amino group (M1) through a three-enzyme cascade (E1–E2–E3). Chain types are diverse, including K48, K63, M1, etc., with different chain types determining functional differences. For example, K48 chains often mediate protein degradation, while K63 chains regulate signaling pathways or DNA damage repair.

 

2. Advances in Mass Spectrometry Technology for Ubiquitinomics

(1) Antibody Enrichment Strategy: Use antibodies against 'di-Glycine residues (di-Gly)' to capture ubiquitinated peptide fragments.

(2) High-resolution mass spectrometry platforms: such as Orbitrap Fusion Lumos, can cover up to 10,000+ ubiquitination sites.

(3) Labeling Quantification Methods: such as TMT (Tandem Mass Tags).

(4) Data-independent acquisition (DIA) enhances reproducibility and coverage.

 

II. Core Applications of Ubiquitinomics in Biological Research

1. Cell Cycle and Proliferation Regulation

(1) K48 chain ubiquitination of Cyclin E regulates its degradation during the G1/S phase.

(2) The regulatory mechanism of CUL3 as an E3 ligase on Cyclin has been confirmed through ubiquitinomics.

(3) Abnormalities in this mechanism are closely related to tumorigenesis.

 

2. DNA Damage Response and Genome Stability

(1) K63 chain ubiquitination of PCNA promotes polymerase replacement.

(2) Ubiquitin profiling can reveal time-dependent modification patterns in DDR reactions.

(3) Combined with UV or chemotherapy drug stimulation, identify DNA repair targets.

 

3. Signal Transduction and Immunity

(1) NF-κB activation pathway depends on K63 chain ubiquitination events.

(2) RIG-I-mediated innate immune activation also involves the ubiquitin regulation network.

(3) Ubiquitinomics combined with interactomics can identify ubiquitination sites on complexes.

 

III. Translational Medicine Perspective of Ubiquitinomics: Ubiquitination Regulation Mechanisms in Diseases

1. Ubiquitinomics in Cancer

(1) Upregulation of UBR5 promotes ubiquitination in DNA repair.

(2) Ubiquitinomics assists in identifying new markers such as the K48 ubiquitin chain.

(3) Predict response to PARP inhibitors or immunotherapy drugs.

 

2. Neurodegenerative Diseases

(1) Parkin inactivation causes mitochondrial autophagy impairment.

(2) Ubiquitin profiling reflects Parkin-dependent ubiquitin cluster changes.

(3) Can serve as an early monitoring indicator for disease progression.

 

3. Autoimmune and Metabolic Disorders

(1) A20 inhibits ubiquitination events in rheumatoid arthritis.

(2) IRS1 ubiquitination regulates insulin signaling pathway.

(3) High-fat diet enhances K48 ubiquitination leading to insulin resistance. Ubiquitinomics provides new strategies for identifying metabolic intervention targets.

 

IV. New Directions and Cutting-edge Technologies in Ubiquitinomics Research

1. Ubiquitin-Phosphoproteomics Joint Analysis

(1) Significant synergistic effects of PTMs in signaling pathways.

(2) Achieving signal deconstruction through parallel mass spectrometry identification in the same sample.

 

2. Single-Cell Ubiquitinomics

(1) Utilize highly sensitive mass spectrometry to depict single-cell ubiquitin profiles.

(2) Used for analyzing tumor heterogeneity and immune status.

 

3. Bioinformatics and AI Collaborative Analysis

(1) Machine learning predicts ubiquitin sites.

(2) Reconstruct ubiquitination network maps.

 

V. Technical Advantages of Biotech Ubiquitinomics by Biotech Park

• One-stop platform: Comprehensive support from sample to data interpretation.

• High coverage: Orbitrap + efficient enrichment, identifying >12,000 sites.

• Customized solutions: Optimized workflows for multiple directions of tumor, neural, and immune research.

• Authoritative report: Compliant with MIAPE, supports database submission and publication requirements.

 

Ubiquitination proteomics has become a key method for interpreting cellular mechanisms, disease development, and translational medicine research. In the future, the integration of ubiquitinome and phosphoproteome, single-cell ubiquitin profiling, and AI-assisted analysis will further enhance data accuracy and clinical relevance. Biotech-Pack BioTech is committed to building a higher-dimensional, deeper ubiquitinome technology platform to provide key support for basic research and precision medicine.

 

Biotech-Pack BioTech - Characterization of bioproducts, high-quality service provider of multi-omics mass spectrometry detection

 

Related services:

Quantitative ubiquitination proteomics research